DR. ELS Decrop SRL
DR. ELS Decrop reported total assets of 194,171 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of DR. ELS Decrop shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +103 % Total assets +31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. ELS Decrop's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 29,923 € | ||||
| Equity | 185,984 € | ||||
| Cash | 169,381 € | ||||
| EBITDA | 42,894 € | ||||
| Total assets | 194,171 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
DR. ELS Decrop's financial analysis
- Solvency95.8%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. ELS Decrop
DR. ELS Decrop's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0809.990.184
- VAT number
- BE0809990184
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 19 Feb 2009
- Registered office
- 2860 Sint-Katelijne-Waver
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
DR. ELS Decrop (SRL) has been based in Sint-Katelijne-Waver since 2009, active in: medical specialists activities. For 2025, it reports a net profit of 29,923 € and equity of 185,984 €; its revenue is not published. Its solvency stands at 95.8%, above the median of its sector (72.2%).
Companies similar to DR. ELS Decrop
Companies in the same business, of comparable size and area, outside its group.
- CaroDcf Medical specialists activities Ottignies-Louvain-la-Neuve · balance sheet 194,130 €
- Dr. Plankova Zuzana Medical specialists activities Ghent · balance sheet 194,367 €
- Aurore LE Dermatology Medical specialists activities Lasne · balance sheet 193,885 €
- ISA Bokoko Medical specialists activities Montigny-le-Tilleul · balance sheet 193,784 €
- Dr. A.S. Bonte Medical specialists activities Antwerp · balance sheet 194,662 €
- Dokter Karen VAN Vlimmeren Anesthesie Medical specialists activities Schilde · balance sheet 194,717 €
- JCB Médical Medical specialists activities Anderlecht · balance sheet 193,563 €
- Dr. Hanne Liessens Medical specialists activities Bierbeek · balance sheet 194,913 €
Frequently asked questions about DR. ELS Decrop
What is the revenue of DR. ELS Decrop?
DR. ELS Decrop files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. ELS Decrop?
In Belgium, the VAT number is the company number prefixed with BE: BE0809990184 for DR. ELS Decrop, if the company is VAT-registered. Its company number (CBE) is 0809.990.184.
Where is the registered office of DR. ELS Decrop?
According to the CBE register, the registered office of DR. ELS Decrop is in 2860 Sint-Katelijne-Waver.
What is the equity of DR. ELS Decrop?
At the close of the 2025 financial year, the equity of DR. ELS Decrop amounts to 185,984 €, a solvency of 95.8% of total assets.
Who manages DR. ELS Decrop?
The register lists 1 active mandates at DR. ELS Decrop. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. ELS Decrop
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →